Wedbush Bullish on Black Diamond Therapeutics (BDTX) Following Progress in Silevertinib Program
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) is on our list of the top 10 stocks under $5 that could triple. As of March 17, 2026, Black Diamond Therapeutics, Inc.







